Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

At the heart of the deal is Relation’s Lab-in-the-Loop platform, which uses AI models to improve understanding of diseases and guide clinical development programs. Months after securing an approval ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

Proposed tariffs that are the highest in a century. Threatened annexations of other countries. Pulling out of the Paris agreements to fight climate change. Slashes to the funding of public health ...

Exercise is generally good for you, but a new high-quality clinical trial finds that it’s so good, it can even knock back colon cancer—and, in fact, rival some chemotherapy treatments. The finding ...

Panelists discuss how significant gaps in current uncomplicated urinary tract infection (UTI) therapies include insufficient nonantibiotic preventive strategies, limited options for ...

Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between partners suggests that ...

It’s common for patients to fear that their cancer will return. Breast cancer is the most prevalent form of cancer, so it makes sense that fear of recurrence among its survivors is especially ...